相关实验视频

Updated: May 7, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

通过 TRAIL 融合蛋白质,把 TRAIL 变成更好的抗癌疗法

Yan Wang¹, Xin Qian², Yubo Wang³

¹College of Agroforestry and Medicine, The Open University of China, Beijing, China.

Cancer medicine

|December 31, 2024

概括

与瘤亡因子相关的亡诱导联结体 (TRAIL) 融合蛋白正在开发中,以改善癌症治疗. 这些战略旨在加强TRAIL.

科学领域:

生物化学生物化学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

与瘤亡因子相关的诱导亡的配体 (TRAIL) 显示选择性瘤细胞诱导亡.
用重组TRAIL和抗体进行的临床试验产生了有限的疗效.
TRAIL融合蛋白代表了优化癌症治疗的关键策略.

研究的目的:

审查和分类TRAIL的融合策略.
引导开发更有效的基于 TRAIL 的抗癌疗法.

主要方法:

三十年来对TRAIL融合蛋白研究进行了全面的文献搜索.
基于其功能结果的融合策略的分类.

主要成果:

TRAIL的融合策略包括稳定trimers,增强聚合,并改善瘤部位积累.
其他策略包括将TRAIL与抗体片段/融合,装饰免疫细胞,延长半衰期和克服耐药性.
有多种方法可以提高TRAIL的抗癌潜力.

结论:

再组合的 TRAIL 融合蛋白为癌症治疗提供了有前途的途径.
核聚变战略的合理设计对于提高TRAIL有效性至关重要.
进一步的开发旨在将TRAIL融合蛋白转化为有效的临床疗法.

关键词:

轨道的轨道是一个轨道.灭症 (apoptosis) 是一种死亡的过程.癌症癌症癌症癌症癌症融合蛋白质是融合蛋白质的组成部分.电阻的阻力可以

更多相关视频

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...